We are live on ! Find out more
CLOS

Compagnie Lombard Odier SCmA Portfolio holdings

AUM $9.25B
1-Year Est. Return 27.04%
This Fund
S&P 500
This Quarter Est. Return
+5.59%
1 Year Est. Return
+27.04%
3 Year Est. Return
+108.78%
5 Year Est. Return
+129.43%
10 Year Est. Return
+503.05%
AUM
$2.52B
AUM Growth
+$107M
Cap. Flow
-$44M
Cap. Flow %
-1.75%
Top 10 Hldgs %
39.63%
Holding
928
New
75
Increased
183
Reduced
220
Closed
49

Top Sells

Rank Stock Value
1
AGN
Allergan Inc
AGN
+$41.4M
2
AAPL icon
Apple
AAPL
+$22.1M
3
TPR icon
Tapestry
TPR
+$17.3M
4
KO icon
Coca-Cola
KO
+$16.9M
5
MDLZ icon
Mondelez International
MDLZ
+$9.96M

Sector Composition

Rank Sector Weight
1 Healthcare 16.26%
2 Consumer Staples 13.28%
3 Financials 12.58%
4 Energy 10.49%
5 Technology 10.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MJN
26
DELISTED
Mead Johnson Nutrition Company
MJN
$21.8M 0.87%
234,038
+175,600
+300% +$15.4M
MCD icon
27
McDonald's
MCD
$194B
$20.6M 0.82%
204,973
-1,283
-0.6% -$130K
XOM icon
28
ExxonMobil
XOM
$635B
$19.9M 0.79%
197,425
+26,822
+16% +$2.71M
MSFT icon
29
Microsoft
MSFT
$3.67T
$19.8M 0.79%
474,083
-86,320
-15% -$3.49M
INTC icon
30
Intel
INTC
$506B
$18.8M 0.75%
609,768
-48,002
-7% -$1.32M
PVH icon
31
PVH
PVH
$4.07B
$17.8M 0.71%
152,481
+67,785
+80% +$8.43M
UN
32
DELISTED
Unilever NV New York Registry Shares
UN
$17.4M 0.69%
397,590
PBR icon
33
Petrobras
PBR
$120B
$16.3M 0.65%
1,116,745
+745
+0.1% +$10.9K
KMB icon
34
Kimberly-Clark
KMB
$36.2B
$16M 0.64%
150,453
-521
-0.3% -$55.4K
HAL icon
35
Halliburton
HAL
$27.1B
$15.8M 0.63%
222,310
+5,797
+3% +$372K
BMY icon
36
Bristol-Myers Squibb
BMY
$130B
$14.6M 0.58%
300,331
-729
-0.2% -$35.9K
CVX icon
37
Chevron
CVX
$371B
$14.3M 0.57%
109,739
+9,188
+9% +$1.14M
EOG icon
38
EOG Resources
EOG
$71.4B
$12.2M 0.48%
104,016
+55,910
+116% +$5.88M
CSCO icon
39
Cisco
CSCO
$477B
$11.9M 0.47%
478,193
-89,436
-16% -$2.13M
QCOM icon
40
Qualcomm
QCOM
$168B
$9.9M 0.39%
125,006
-26,604
-18% -$2.11M
BN icon
41
Brookfield
BN
$108B
$9.37M 0.37%
906,772
+1,815
+0.2% +$18.2K
VWO icon
42
Vanguard FTSE Emerging Markets ETF
VWO
$123B
$9.24M 0.37%
214,155
+33,516
+19% +$1.41M
QQQ icon
43
Invesco QQQ Trust
QQQ
$479B
$8.91M 0.35%
94,873
+32,190
+51% +$2.87M
CAT icon
44
Caterpillar
CAT
$400B
$8.74M 0.35%
80,397
-1,217
-1% -$128K
PFE icon
45
Pfizer
PFE
$147B
$8.48M 0.34%
301,070
+12,095
+4% +$345K
AGN
46
DELISTED
Allergan Inc
AGN
$8.04M 0.32%
47,487
-265,623
-85% -$41.4M
FCX icon
47
Freeport-McMoran
FCX
$95.8B
$8.03M 0.32%
220,019
-13,580
-6% -$465K
B
48
Barrick Mining
B
$68.7B
$7.95M 0.32%
433,381
+45,600
+12% +$790K
TXN icon
49
Texas Instruments
TXN
$256B
$7.86M 0.31%
164,376
+411
+0.3% +$19.2K
MON
50
DELISTED
Monsanto Co
MON
$7.83M 0.31%
62,721
-50,200
-44% -$5.88M

Similar funds

Compagnie Lombard Odier SCmA's Q2 2014 Portfolio in Review

As of Q2 2014, Compagnie Lombard Odier SCmA held 928 positions worth $2.52B, up 4.5% from $2.41B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Compagnie Lombard Odier SCmA's Q2 2014 filing shows 75 new, 183 increased, 220 reduced and 49 closed positions. Its largest new stake was Diebold Nixdorf Incorporated: 28,942 shares worth $1.16M. The largest sale was Allergan Inc, an estimated $41.4M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Consumer Staples and Financials.

  • Compagnie Lombard Odier SCmA's largest Q2 2014 buy was Diebold Nixdorf Incorporated: 28,942 shares worth $1.16M.
  • Compagnie Lombard Odier SCmA added most to Gilead Sciences in Q2 2014, an estimated $48M increase.
  • Compagnie Lombard Odier SCmA's biggest Q2 2014 reduction was Allergan Inc, cutting an estimated $41.4M.
  • Compagnie Lombard Odier SCmA fully exited VanEck Oil Services ETF in Q2 2014, selling an estimated $8.32M.
  • Compagnie Lombard Odier SCmA's ten largest holdings make up 40% of its $2.52B portfolio in Q2 2014.
  • Compagnie Lombard Odier SCmA opened 75 new positions and closed 49 in Q2 2014.
  • Compagnie Lombard Odier SCmA's portfolio value rose 4.5% quarter-over-quarter to $2.52B.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q2 2014, filed 14 Aug 2014.